Successful maintenance of molecular remission in chronic myelogenous leukaemia during pregnancy with transition from imatinib to pegylated interferon

Ellis M.; Mills A. K.

首页> 外文期刊>Internal medicine journal >Successful maintenance of molecular remission in chronic myelogenous leukaemia during pregnancy with transition from imatinib to pegylated interferon

【24h】

Successful maintenance of molecular remission in chronic myelogenous leukaemia during pregnancy with transition from imatinib to pegylated interferon

机译：从伊马替尼向聚乙二醇化干扰素过渡期间，成功维持妊娠期间慢性粒细胞性白血病的分子缓解

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Internal medicine journal》 |2015年第3期|共2页
作者
Ellis M.; Mills A. K.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内科学;
关键词

相似文献

外文文献
中文文献
专利

1. Successful maintenance of molecular remission in chronic myelogenous leukaemia during pregnancy with transition from imatinib to pegylated interferon [J] . Ellis M., Mills A. K. Internal medicine journal . 2015,第3期

机译：从伊马替尼向聚乙二醇化干扰素过渡期间，成功维持妊娠期间慢性粒细胞性白血病的分子缓解
2. Pregnancy under treatment of imatinib and successful labor in a patient with chronic myelogenous leukemia (CML). Outcome of discontinuation of imatinib therapy after achieving a molecular remission. [J] . Ali R, Ozkalemkas F, Ozcelik T, Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis . 2005,第8期

机译：伊马替尼治疗下的妊娠和慢性骨髓性白血病（CML）患者的成功分娩。达到分子缓解后终止伊马替尼治疗的结果。
3. Durable Molecular Complete Remission Induced by Low-dose Imatinib plus Low-dose Interferon Alpha in a Patient with Chronic Myelogenous Leukaemia [J] . J Takeuchi, K Miura, Y Hatta, Journal of International Medical Research . 2006,第1期

机译：小剂量伊马替尼加小剂量干扰素α诱导的慢性粒细胞白血病患者持久的分子完全缓解
4. Proteomic Analysis of the Cytoskeleton Regulation in Chronic Myelogenous Leukemia Cells JURL-MK1: Effect of Imatinib Mesylate Treatment [C] . Petr Halada, Katerina Peslova, Dana Grebenova, ASMS Conference on Mass Spectrometry and Allied Topics . 2008

机译：慢性髓性白血病细胞Jull-MK1中细胞骨架调控的蛋白质组学分析：伊马替尼甲磺酸盐处理的影响
5. Targeting Chronic Myelogenous Leukemia with IMATINIB and Glycyrrhizic Acid Combination Therapy [D] . Mohaban, Adir. 2022

机译：用伊马替尼和甘草组合治疗靶向慢性髓性白血病
6. A successful renal transplantation for renal failure after dasatinib-induced thrombotic thrombocytopenic purpura in a patient with imatinib-resistant chronic myelogenous leukaemia on nilotinib [O] . Suella Martino, Etienne Daguindau, Christophe Ferrand, 2013

机译：尼洛替尼对伊马替尼耐药的慢性粒细胞性白血病患者在达沙替尼诱导的血栓性血小板减少性紫癜后成功进行肾衰竭肾移植
7. Durable Molecular Complete Remission Induced by Low-dose Imatinib plus Low-dose Interferon Alpha in a Patient with Chronic Myelogenous Leukaemia [O] . J Takeuchi, K Miura, Y Hatta, 2006

机译：低剂量伊替尼诱导的耐用分子完全缓解加上慢性髓性白血病的患者中的低剂量干扰素α

Successful maintenance of molecular remission in chronic myelogenous leukaemia during pregnancy with transition from imatinib to pegylated interferon

著录项

相似文献

相关主题

期刊订阅